Craft

Oragenics

Stock Price

$1.6

2024-05-16

Market Capitalization

$7.3 M

2024-05-16

Revenue

$37.7 K

FY, 2023

Oragenics Summary

Company Summary

Overview
Oragenics is focused on becoming a leader in novel antibiotics against infectious disease and on developing effective treatments for oral mucositis. Oragenics, Inc. has established two exclusive worldwide channel collaborations with Intrexon Corporation Inc., a synthetic biology company. The collaborations allow Oragenics access to Intrexon's proprietary technologies toward the goal of accelerating the development of much needed new antibiotics that can work against resistant strains of bacteria and the development of biotherapeutics for oral mucositis and other diseases and conditions of the oral cavity, throat, and esophagus.
Type
Public
Status
Active
Founded
1996
HQ
Tampa, FL, US | view all locations
Website
http://www.oragenics.com/
Cybersecurity rating
Sectors

Key People

  • Charles L. Pope, Director

    • Alan Dunton, Director

      • Robert Koski, Director

        • Kim Murphy, Director

          LocationsView all

          1 location detected

          • Tampa, FL HQ

            United States

            4902 Eisenhower Blvd N #125

          Oragenics Financials

          Summary Financials

          Revenue (FY, 2023)
          $37.7K
          Net income (FY, 2023)
          ($20.7M)
          Cash (FY, 2023)
          $3.5M
          EBIT (FY, 2023)
          ($20.9M)
          Enterprise value
          $5.4M

          Footer menu